Volume 119, Issue 1 , Pages 206-212, January 2007
Esophageal remodeling in pediatric eosinophilic esophagitis
Background
Eosinophils are associated with airway remodeling in asthma, but studies have not yet determined whether eosinophilic esophagitis (EE) is associated with esophageal remodeling.
Objective
We performed quantitative immunohistochemical analysis of remodeling changes in esophageal biopsy specimens from children with and without EE to evaluate if there were changes in the esophagus of pediatric patients with EE akin to airway remodeling. In addition, we determined whether the esophagus of patients with EE had increased levels of expression of TGF-β1 and its signaling molecule, phosphorylated SMAD2/3 (phospho-SMAD2/3).
Methods
To determine esophageal levels of eosinophilic inflammation, fibrosis, and vascular activation, endoscopically obtained esophageal biopsy specimens from 7 patients with EE (5 strictured, 2 nonstrictured), 7 with gastroesophageal reflux disease, and 7 normal patients were processed for immunohistology, trichrome staining, and assessment of levels of expression of TGF-β1, phospho-SMAD2/3, and vascular cell adhesion molecule 1.
Results
Esophageal biopsies in patients with EE demonstrated increased levels of subepithelial fibrosis and increased expression of TGF-β1 and its signaling molecule phospho-SMAD2/3 compared with gastroesophageal reflux disease and normal control patients. In addition, esophageal biopsies in patients with EE demonstrated an increased vascular density and an increased expression of the vascular endothelial adhesion molecule, vascular cell adhesion molecule 1.
Conclusion
Previously unrecognized esophageal remodeling changes analogous to aspects of airway remodeling are detectable in the subepithelial region of the esophagus in pediatric patients with EE.
Clinical implications
Pediatric patients with EE demonstrate increased fibrosis, vascularity, and vascular activation in the esophagus that may contribute to stricture formation and potentially provide a basis for stratifying patients with EE on the basis of disease severity and/or prognosis.
Key words: Eosinophilic esophagitis, children, vascularity, fibrosis, strictures
Abbreviations used: BZH, Basal zone hyperplasia, EE, Eosinophilic esophagitis, EGD, Esophagogastroduodenoscopy, GERD, Gastroesophageal reflux disease, hpf, High-power field, LP, Lamina propria, Phospho-SMAD2/3, Phosphorylated SMAD2/3, VCAM-1, Vascular cell adhesion molecule 1, vWF, von Willebrand Factor
Supported by the American Academy of Allergy, Asthma & Immunology Education and Research Trust (ERT) Clinical Research Grant (S.S.A.), National Institutes of Health T32 Training award AI 007469 (S.S.A.), and National Institutes of Health grant AI 38425 (D.H.B.).Disclosure of potential conflict of interest: S. S. Aceves has received grant support from the American Academy of Allergy, Asthma and Immunology Clinical ERT. D. H. Broide has received grant support from the National Institutes of Health. The other authors have declared that they have no conflict of interest.
PII: S0091-6749(06)02136-1
doi:10.1016/j.jaci.2006.10.016
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 119, Issue 1 , Pages 206-212, January 2007
